Jarlais Don C Des, Arasteh Kamyar, Feelemyer Jonathan, McKnight Courtney, Barnes David M, Tross Susan, Perlman David C, Campbell Aimee N C, Cooper Hannah L F, Hagan Holly
Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Icahn School of Medicine at Mount Sinai, New York, NY, United States.
J Subst Abuse Treat. 2016 Dec;71:48-53. doi: 10.1016/j.jsat.2016.08.015. Epub 2016 Aug 21.
Transitioning from injecting to non-injecting routes of drug administration can provide important individual and community health benefits. We assessed characteristics of persons who had ceased injecting while continuing to use heroin and/or cocaine in New York City.
We recruited subjects entering Mount Sinai Beth Israel detoxification and methadone maintenance programs between 2011 and 2015. Demographic information, drug use histories, sexual behaviors, and "reverse transitions" from injecting to non-injecting drug use were assessed in structured face-to-face interviews. There were 303 "former injectors," operationally defined as persons who had injected at some time in their lives, but had not injected in at least the previous 6 months. Serum samples were collected for HIV and HCV testing.
Former injectors were 81% male, 19% female, 17% White, 43% African-American, and 38% Latino/a, with a mean age of 50 (SD=9.2), and were currently using heroin and/or cocaine. They had injected drugs for a mean of 14 (SD=12.2) years before ceasing injection, and a mean of 13 (SD=12) years had elapsed since their last injection. HIV prevalence among the sample was 13% and HCV prevalence was 66%. The former injectors reported a wide variety of reasons for ceasing injecting. Half of the group appeared to have reached a point where relapse back to injecting was no longer problematic: they had not injected for three or more years, were not deliberately using specific techniques to avoid relapse to injecting, and were not worried about relapsing to injecting.
Former injectors report very-long term behavior change toward reduced individual and societal harm while continuing to use heroin and cocaine. The behavior change appears to be self-sustaining, with full replacement of an injecting route of drug administration by a non-injecting route of administration. Additional research on the process of long-term cessation of injecting should be conducted within a "combined prevention and care" approach to HIV and HCV infection among persons who use drugs.
从注射吸毒方式转变为非注射吸毒方式可为个人和社区健康带来重要益处。我们评估了纽约市已停止注射但仍继续使用海洛因和/或可卡因的人群的特征。
我们招募了2011年至2015年间进入西奈山贝斯以色列戒毒和美沙酮维持治疗项目的受试者。在结构化的面对面访谈中评估了人口统计学信息、吸毒史、性行为以及从注射吸毒到非注射吸毒的“反向转变”情况。共有303名“ former injectors”(暂译为“既往注射吸毒者”),其操作定义为在生命中的某个时刻注射过毒品,但至少在过去6个月内未注射过的人。采集血清样本进行艾滋病毒和丙型肝炎病毒检测。
既往注射吸毒者中男性占81%,女性占19%,白人占17%,非裔美国人占43%,拉丁裔占38%,平均年龄为50岁(标准差=9.2),目前正在使用海洛因和/或可卡因。他们在停止注射前平均注射毒品14年(标准差=12.2),自最后一次注射以来平均已过去13年(标准差=12)。样本中艾滋病毒感染率为13%,丙型肝炎病毒感染率为66%。既往注射吸毒者报告了停止注射的多种原因。该组中有一半人似乎已达到不再有复吸注射吸毒问题的阶段:他们已经三年或更长时间没有注射,没有刻意使用特定技巧来避免复吸注射,也不担心复吸注射。
既往注射吸毒者报告称,在继续使用海洛因和可卡因的同时,他们朝着减少个人和社会危害的方向发生了非常长期的行为改变。这种行为改变似乎具有自我维持性,注射吸毒方式已完全被非注射吸毒方式所取代。应在针对吸毒者艾滋病毒和丙型肝炎病毒感染的“综合预防与护理”方法框架内,对长期停止注射的过程开展更多研究。